These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2465485

  • 1. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    Woynarowski JM, McHugh M, Sigmund RD, Beerman TA.
    Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
    [Abstract] [Full Text] [Related]

  • 2. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
    McHugh MM, Woynarowski JM, Sigmund RD, Beerman TA.
    Biochem Pharmacol; 1989 Jul 15; 38(14):2323-8. PubMed ID: 2473754
    [Abstract] [Full Text] [Related]

  • 3. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
    McHugh MM, Sigmund RD, Beerman TA.
    Biochem Pharmacol; 1990 Feb 15; 39(4):707-14. PubMed ID: 1689578
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
    Albert FG, Eckdahl TT, Fitzgerald DJ, Anderson JN.
    Biochemistry; 1999 Aug 03; 38(31):10135-46. PubMed ID: 10433722
    [Abstract] [Full Text] [Related]

  • 5. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Poot M, Hiller KH, Heimpel S, Hoehn H.
    Exp Cell Res; 1995 May 03; 218(1):326-30. PubMed ID: 7537696
    [Abstract] [Full Text] [Related]

  • 6. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM, Sigmund RD, Beerman TA.
    Biochemistry; 1989 May 02; 28(9):3850-5. PubMed ID: 2473776
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
    Bell A, Kittler L, Löber G, Zimmer C.
    J Mol Recognit; 1997 May 02; 10(6):245-55. PubMed ID: 9770648
    [Abstract] [Full Text] [Related]

  • 9. Enhancement and alteration of bleomycin-catalyzed site-specific DNA cleavage by distamycin A and some minor groove binders.
    Yamamoto K, Kawanishi S.
    Biochem Biophys Res Commun; 1992 Feb 28; 183(1):292-9. PubMed ID: 1371920
    [Abstract] [Full Text] [Related]

  • 10. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
    Smith PJ, Bell SM, Dee A, Sykes H.
    Carcinogenesis; 1990 Apr 28; 11(4):659-65. PubMed ID: 2157558
    [Abstract] [Full Text] [Related]

  • 11. Carbocyclic analogues of netropsin and distamycin: DNA-binding properties and inhibition of DNA topoisomerases.
    Bartulewicz D, Bielawski K, Bielawska A.
    Arch Pharm (Weinheim); 2002 Nov 28; 335(9):422-6. PubMed ID: 12447915
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
    Mortensen UH, Stevnsner T, Krogh S, Olesen K, Westergaard O, Bonven BJ.
    Nucleic Acids Res; 1990 Apr 25; 18(8):1983-9. PubMed ID: 2159632
    [Abstract] [Full Text] [Related]

  • 14. Molecular recognition of B-DNA by Hoechst 33258.
    Harshman KD, Dervan PB.
    Nucleic Acids Res; 1985 Jul 11; 13(13):4825-35. PubMed ID: 2410856
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
    Tolner B, Hartley JA, Hochhauser D.
    Mol Pharmacol; 2001 Apr 11; 59(4):699-706. PubMed ID: 11259613
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
    Beria I, Baraldi PG, Cozzi P, Caldarelli M, Geroni C, Marchini S, Mongelli N, Romagnoli R.
    J Med Chem; 2004 May 06; 47(10):2611-23. PubMed ID: 15115402
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D, Rusak M, Miltyk W, Midura-Nowaczek K.
    Arch Pharm (Weinheim); 2009 Feb 06; 342(2):87-93. PubMed ID: 19173336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.